This observation was recently confirmed and extended both in yeast and human cancer cells, by showing that a peptide corresponding to the Tom20 domain interacting with BCL-2 was able to prevent the mitochondrial localization of BCL-2 [25]. Here, BCL2 is linked to cancer.